natgillin/translations-raw huggingface dataset:
Since the objective of this Directive, namely to extend the application of the Union criminal law provisions that apply to illicit drug trafficking to new psychoactive substances posing severe public health risks and, where applicable, severe social risks, cannot be sufficiently achieved by the Member States acting alone, but can rather be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union (TEU).
Države članice trebale bi poduzeti sve napore da taj rok skrate u najvećoj mogućoj mjeri.
In accordance with the principle of proportionality as set out in that Article, this Directive does not go beyond what is necessary in order to achieve that objective.
S obzirom na to da cilj ove Direktive, proširenje primjene odredaba kaznenog prava Unije koje se primjenjuju na nezakonitu trgovinu drogom na nove psihoaktivne tvari koje predstavljaju ozbiljan rizik za javno zdravlje i, ako je to primjenjivo, ozbiljan rizik za društvo, ne mogu dostatno ostvariti države članice, nego se on na bolji način može ostvariti na razini Unije, Unija može donijeti mjere u skladu s načelom supsidijarnosti utvrđenim u članku 5.
This Directive respects the fundamental rights and observes the principles recognised by the Charter of Fundamental Rights of the European Union, and in particular the right to an effective remedy and to a fair trial, the presumption of innocence and the right of defence, the right not to be tried or punished twice in criminal proceedings for the same criminal offence and the principles of legality and proportionality of criminal offences and penalties.
Ugovora o Europskoj uniji (TEU).
As this Directive together with Regulation (EU) 2017/2101, is designed to replace the mechanism established by Decision 2005/387/JHA, that Decision should be repealed.
U skladu s načelom proporcionalnosti utvrđenim u tom članku, ova Direktiva ne prelazi ono što je potrebno za ostvarivanje tog cilja.
In accordance with Article 3 of Protocol No 21 on the position of the United Kingdom and Ireland in respect of the area of freedom, security and justice, annexed to the TEU and to the TFEU, Ireland has notified its wish to take part in the adoption and application of this Directive.
Ovom se Direktivom poštuju temeljna prava i načela priznata Poveljom Europske unije o temeljnim pravima, posebno pravo na učinkovit pravni lijek i pravično suđenje, pretpostavku nedužnosti i pravo na obranu, pravo izbjegavanja dvostrukog suđenja ili kažnjavanja za isto kazneno djelo te načelo zakonitosti i proporcionalnosti kaznenih djela i kazni.
In accordance with Articles 1 and 2 of Protocol No 21 on the position of the United Kingdom and Ireland in respect of the area of freedom, security and justice, annexed to the TEU and to the TFEU, and without prejudice to Article 4 of that Protocol, the United Kingdom is not taking part in the adoption of this Directive and is not bound by it or subject to its application.
Budući da se ovom Direktivom i Uredbom (EU) 2017/2101 namjerava zamijeniti mehanizam uspostavljen Odlukom 2005/387/PUP, tu bi Odluku trebalo staviti izvan snage.
In accordance with Articles 1 and 2 of Protocol No 22 on the position of Denmark, annexed to the TEU and to the TFEU, Denmark is not taking part in the adoption of this Directive and is not bound by it or subject to its application.
U skladu s člankom 3.
Framework Decision 2004/757/JHA should therefore be amended accordingly,
Protokola br. 21 o stajalištu Ujedinjene Kraljevine i Irske s obzirom na područje slobode, sigurnosti i pravde, priloženog UEU-u i UFEU-u, Irska je obavijestila da želi sudjelovati u donošenju i primjeni ove Direktive.
HAVE ADOPTED THIS DIRECTIVE:
U skladu s člancima 1. i 2.
Article 1
Protokola br. 21 o stajalištu Ujedinjene Kraljevine i Irske s obzirom na područje slobode, sigurnosti i pravde, priloženog UEU-u i UFEU-u, i ne dovodeći u pitanje članak 4. navedenog protokola, Ujedinjena Kraljevina ne sudjeluje u donošenju ove Direktive te ona za nju nije obvezujuća niti se na nju primjenjuje.
Amendments to Framework Decision 2004/757/JHA
U skladu s člancima 1. i 2.
Framework Decision 2004/757/JHA is amended as follows:
Protokola br. 22 o stajalištu Danske, priloženog UEU-u i UFEU-u, Danska ne sudjeluje u donošenju ove Direktive te ona za nju nije obvezujuća niti se na nju primjenjuje.
Article 1 is amended as follows:
Okvirnu odluku 2004/757/PUP trebalo bi stoga na odgovarajući način izmijeniti,
point 1 is replaced by the following:
DONIJELI SU OVU DIREKTIVU:
“drug” means any of the following:
Članak 1.
a substance covered by the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol, or by the 1971 United Nations Convention on Psychotropic Substances;
Izmjene Okvirne odluke 2004/757/PUP
any of the substances listed in the Annex;’;
Okvirna odluka 2004/757/PUP mijenja se kako slijedi:
the following points are added:
1.
“new psychoactive substance” means a substance in pure form or in a preparation that is not covered by the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol, or by the 1971 United Nations Convention on Psychotropic Substances but may pose health or social risks similar to those posed by the substances covered by those Conventions;
Članak 1. mijenja se kako slijedi:
“preparation” means a mixture containing one or more new psychoactive substances.’;
točka 1. zamjenjuje se sljedećim:
the following Articles are inserted:
‚droga’ znači bilo što od sljedećeg:
‘Article 1a
tvar koja je obuhvaćena Jedinstvenom konvencijom Ujedinjenih naroda o opojnim drogama iz 1961., kako je izmijenjena Protokolom iz 1972., ili Konvencijom Ujedinjenih naroda o psihotropnim tvarima iz 1971.;
Procedure for including new psychoactive substances in the definition of “drug”
bilo koja od tvari navedenih u Prilogu;”;
Based on a risk assessment or combined risk assessment carried out pursuant to Article 5c of Regulation (EC) No 1920/2006 of the European Parliament and of the Council, and in accordance with the criteria set out in paragraph 2 of this Article, the Commission shall, without undue delay, adopt a delegated act in accordance with Article 8a amending the Annex to this Framework Decision in order to add the new psychoactive substance or substances to it and provide that the new psychoactive substance or substances pose severe public health risks and, where applicable, severe social risks at Union level, and that it is or they are included in the definition of “drug”.
dodaju se sljedeće točke:
When considering whether to adopt a delegated act as referred to in paragraph 1, the Commission shall take into account whether the extent or patterns of use of the new psychoactive substance and its availability and potential for diffusion within the Union are significant, and whether the harm to health caused by the consumption of the new psychoactive substance, associated with its acute or chronic toxicity and abuse liability or dependence-producing potential, is life-threatening.
‚nova psihoaktivna tvar’ znači tvar u čistom obliku ili pripravku koja nije obuhvaćena Jedinstvenom konvencijom Ujedinjenih naroda o opojnim drogama iz 1961., kako je izmijenjena Protokolom iz 1972., ili Konvencijom Ujedinjenih naroda o psihotropnim tvarima iz 1971., ali može predstavljati rizik za zdravlje ili društvo sličan onom koji predstavljaju tvari obuhvaćene tim konvencijama;
The harm to health is considered life-threatening if the new psychoactive substance is likely to cause death or lethal injury, severe disease, severe physical or mental impairment or a significant spread of diseases, including the transmission of blood-borne viruses.
‚pripravak’ znači mješavina koja sadrži najmanje jednu novu psihoaktivnu tvar.”.
In addition, the Commission shall take into account whether the social harm caused by the new psychoactive substance to individuals and to society is severe, and, in particular, whether the impact of the new psychoactive substance on social functioning and public order is such as to disrupt public order, or cause violent or anti-social behaviour, resulting in harm to the user or to other persons or damage to property, or whether criminal activities, including organised crime, associated with the new psychoactive substance are systematic, involve significant illicit profits or entail significant economic costs.
Umeću se sljedeći članci:
If, within six weeks of the date of receipt of the risk assessment report or the combined risk assessment report in accordance with Article 5c(6) of Regulation (EC) No 1920/2006, the Commission considers that it is not necessary to adopt a delegated act to include the new psychoactive substance or substances in the definition of “drug”, it shall present a report to the European Parliament and to the Council explaining the reasons for not doing so.
„Članak 1.a
As regards new psychoactive substances added to the Annex to this Framework Decision, Member States which have not yet done so shall bring into force the laws, regulations and administrative provisions necessary to apply the provisions of this Framework Decision to those new psychoactive substances as soon as possible but no later than six months after the entry into force of the delegated act amending the Annex.
Postupak za obuhvaćanje novih psihoaktivnih tvari definicijom droge
They shall immediately inform the Commission thereof.
Na temelju procjene rizika ili kombinirane procjene rizika izrađene u skladu s člankom 5.c Uredbe (EZ) br. 1920/2006 Europskog parlamenta i Vijeća i u skladu s kriterijima određenima u stavku 2. ovog članka, Komisija bez nepotrebnog odlaganja donosi delegirani akt u skladu člankom 8.a kojim se Prilog ovoj Okvirnoj odluci izmjenjuje radi dodavanja jedne ili više novih psihoaktivnih tvari i utvrđivanja da jedna ili više novih psihoaktivnih tvari predstavljaju ozbiljan rizik za javno zdravlje i, ako je to primjenjivo, ozbiljan rizik za društvo, na razini Unije te da su obuhvaćene definicijom droge.
When Member States adopt those measures, they shall contain a reference to this Framework Decision or be accompanied by such a reference on the occasion of their official publication.
Razmatrajući donošenje delegiranog akta iz stavka 1.
The methods of making such reference shall be laid down by Member States.
Komisija u obzir uzima jesu li opseg ili obrasci uporabe nove psihoaktivne tvari te njezina dostupnost i potencijal za raspačavanje unutar Unije znatni te je li štetnost za zdravlje prouzročena uzimanjem nove psihoaktivne tvari povezana s njezinom akutnom ili kroničnom toksičnosti i mogućnošću zlouporabe ili uzrokovanja ovisnosti opasna po život.
Article 1b
Štetnost za zdravlje smatra se opasnom po život ako nova psihoaktivna tvar vjerojatno može prouzročiti smrt ili smrtonosne ozljede, tešku bolest, teška fizička ili psihička oštećenja ili znatno širenje bolesti, među ostalim prenošenje virusa koji se prenose krvlju.
National control measures
Komisija usto uzima u obzir je li društvena šteta prouzročena novom psihoaktivnom tvari pojedincima i društvu velika, te posebno je li učinak nove psihoaktivne tvari na funkcioniranje društva i javni red takav da dovodi do ometanja javnog reda te nasilnog ili antisocijalnog ponašanja koje uzrokuje štetu korisniku, drugim osobama ili imovini, odnosno jesu li kriminalne aktivnosti, uključujući organizirani kriminal, u vezi s novom psihoaktivnom tvari sustavne, uključuju li znatnu nezakonitu dobit ili za sobom povlače velike ekonomske troškove.
Without prejudice to the obligations imposed on the Member States under this Framework Decision, Member States may maintain or introduce in their territories, with regard to new psychoactive substances, any national control measures that they consider appropriate.
Ako u vremenu od šest tjedana od dana primitka izvješća o procjeni rizika ili kombiniranog izvješća o procjeni rizika, u skladu s člankom 5.c stavkom 6.
the following Article is inserted:
Uredbe (EZ) br. 1920/2006, Komisija bude smatrala da nije potrebno donijeti delegirani akt o obuhvaćanju jedne ili više novih psihoaktivnih tvari definicijom ‚droge’, ona Europskom parlamentu i Vijeću predstavlja izvješće s objašnjenjem zašto to nije učinila.
‘Article 8a
U pogledu novih psihoaktivnih tvari dodanih Prilogu ovoj Okvirnoj odluci države članice koje to još nisu učinile donose zakone i druge propise potrebne za primjenu odredaba ove Okvirne odluke na te nove psihoaktivne tvari što je prije moguće, ali najkasnije šest mjeseci nakon stupanja na snagu delegiranog akta o izmjeni Priloga.
Exercise of the delegation
One o tome odmah obavješćuju Komisiju.
The power to adopt delegated acts is conferred on the Commission subject to the conditions laid down in this Article.
Kada države članice donose te odredbe, one sadržavaju upućivanje na ovu Okvirnu odluku ili se na nju upućuje prilikom njihove službene objave.
The Commission shall draw up a report in respect of the delegation of power not later than nine months before the end of the five-year period.
Članak 1.b
The delegation of power shall be tacitly extended for periods of an identical duration, unless the European Parliament or the Council opposes such extension not later than three months before the end of each period.
Nacionalne kontrolne mjere
The delegation of power referred to in Article 1a may be revoked at any time by the European Parliament or by the Council.
Ne dovodeći u pitanje obveze država članica na temelju ove Okvirne odluke, države članice mogu u pogledu novih psihoaktivnih tvari na svojemu državnom području zadržati ili uvesti bilo koje nacionalne kontrolne mjere koje smatraju prikladnima.
A decision to revoke shall put an end to the delegation of the power specified in that decision.
Umeće se sljedeći članak:
It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein.
„Članak 8.a
It shall not affect the validity of any delegated acts already in force.
Izvršavanje delegiranja ovlasti
Before adopting a delegated act, the Commission shall consult experts designated by each Member State in accordance with the principles laid down in the Interinstitutional Agreement of 13 April 2016 on Better Law-Making.
Ovlast za donošenje delegiranih akata dodjeljuje se Komisiji podložno uvjetima utvrđenima u ovom članku.
As soon as it adopts a delegated act, the Commission shall notify it simultaneously to the European Parliament and to the Council.
Delegiranje ovlasti prešutno se produljuje za razdoblja jednakog trajanja, osim ako se Europski parlament ili Vijeće tom produljenju usprotive najkasnije tri mjeseca prije kraja svakog razdoblja.
A delegated act adopted pursuant to Article 1a shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object.
3.
That period shall be extended by two months at the initiative of the European Parliament or of the Council.
Europski parlament ili Vijeće u svakom trenutku mogu opozvati delegiranje ovlasti iz članka 1.a.
an Annex, as set out in the Annex to this Directive, is added.
Odlukom o opozivu prekida se delegiranje ovlasti koje je u njoj navedeno.
Article 2
Opoziv počinje proizvoditi učinke sljedećeg dana od dana objave spomenute odluke u Službenom listu Europske unije ili na kasniji dan naveden u spomenutoj odluci.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 23 November 2018.
Prije donošenja delegiranog akta Komisija se savjetuje sa stručnjacima koje je imenovala svaka država članica u skladu s načelima utvrđenima u Međuinstitucijskom sporazumu o boljoj izradi zakonodavstva od 13. travnja 2016.
They shall immediately inform the Commission thereof.
Čim donese delegirani akt, Komisija ga istodobno priopćuje Europskom parlamentu i Vijeću.
When Member States adopt those measures, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication.
Delegirani akt donesen na temelju članka 1.a stupa na snagu samo ako ni Europski parlament ni Vijeće u roku od dva mjeseca od priopćenja tog akta Europskom parlamentu i Vijeću na njega ne podnesu nikakav prigovor ili ako su prije isteka tog roka i Europski parlament i Vijeće obavijestili Komisiju da neće podnijeti prigovore.
Article 3
Taj se rok produljuje za dva mjeseca na inicijativu Europskog parlamenta ili Vijeća.
Repeal of Decision 2005/387/JHA
Dodaje se Prilog, kako je utvrđen u Prilogu ovoj Direktivi.
Decision 2005/387/JHA is repealed with effect from 23 November 2018.
Članak 2.
Notwithstanding paragraph 1, Decision 2005/387/JHA shall continue to apply to new psychoactive substances in respect of which a joint report, as referred to in Article 5 of that Decision, has been submitted before 23 November 2018.
Prenošenje ove Direktive u nacionalno pravo
The Commission shall adopt delegated acts in accordance with paragraphs 4 to 8 of this Article amending the Annex to Framework Decision 2004/757/JHA in order to add to it new psychoactive substances as referred to in paragraph 2 of this Article.
Kada države članice donosu te mjere, one sadržavaju upućivanje na ovu Direktivu ili se na nju upućuje prilikom njihove službene objave.
The power to adopt delegated acts referred to in paragraph 3 shall be conferred on the Commission for a period of two years from 22 November 2017.
Članak 3.
The delegation of power referred to in paragraph 3 may be revoked at any time by the European Parliament or by the Council.
Stavljanje izvan snage Odluke 2005/387/PUP
It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein.
1.
A delegated act adopted pursuant to paragraph 3 shall enter into force only if no objection has been expressed either by the European Parliament or the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object.
Odluka 2005/387/PUP stavlja se izvan snage s učinkom od 23. studenoga 2018.
Article 4
Neovisno o stavku 1.
Entry into force
Odluka 2005/387/PUP nastavlja se primjenjivati na nove psihoaktivne tvari u pogledu kojih je zajedničko izvješće iz članka 5. te odluke podneseno prije 23. studenoga 2018.
This Directive shall enter into force on the day following that of its publication in the Official Journal of the European Union.
Komisija donosi delegirane akte u skladu sa stavcima od 4. do 8. ovog članka kojima se mijenja Prilog Okvirnoj odluci 2004/757/PUP kako bi u njega dodala nove psihoaktivne tvari iz stavka 2. ovog članka.
Article 5
Ovlast za donošenje delegiranih akata iz stavka 3. dodjeljuje se Komisiji na razdoblje od dvije godina počevši od 22. studenoga 2017.
Addressees
5.
This Directive is addressed to the Member States in accordance with the Treaties.
Europski parlament ili Vijeće u svakom trenutku mogu opozvati delegiranje ovlasti iz stavka 3.
Done at Strasbourg, 15 November 2017.
Opoziv počinje proizvoditi učinke sljedećeg dana od dana objave spomenute odluke u Službenom listu Europske unije ili na kasniji dan naveden u spomenutoj odluci.
For the European Parliament
Delegirani akt donesen na temelju stavka 3. stupa na snagu samo ako ni Europski parlament ni Vijeće u roku od dva mjeseca od priopćenja tog akta Europskom parlamentu i Vijeću na njega ne podnesu nikakav prigovor ili ako su prije isteka tog roka i Europski parlament i Vijeće obavijestili Komisiju da neće podnijeti prigovore.
For the Council
Stupanje na snagu
OJ C 177, 11.6.2014, p. 52.
Ova Direktiva stupa na snagu sljedećeg dana od dana objave u Službenom listu Europske unije.
Position of the European Parliament of 17 April 2014 (not yet published in the Official Journal) and position of the Council at first reading of 25 September 2017 (not yet published in the Official Journal).
Članak 5.
Position of the European Parliament of 24 October 2017 (not yet published in the Official Journal).
Adresati
Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
Ova je Direktiva upućena državama članicama u skladu s Ugovorima.
Joint Action 97/396/JHA of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs (OJ L 167, 25.6.1997, p. 1).
Sastavljeno u Strasbourgu 15. studenoga 2017.
Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (OJ L 127, 20.5.2005, p. 32).
Za Europski parlament
Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances (see page 1 of this Official Journal).
Predsjednik
OJ L 123, 12.5.2016, p. 1.
Za Vijeće
Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (OJ L 376, 27.12.2006, p. 1).’;
SL C 177, 11.6.2014., str.
OJ L 123, 12.5.2016, p. 1.’;
52.
ANNEX
Stajalište Europskog parlamenta od 17. travnja 2014. (još nije objavljeno u Službenom listu) i stajalište Vijeća na prvom čitanju od 25. rujna 2017.
List of substances referred to in point (b) of point 1 of Article 1
(još nije objavljeno u Službenom listu).
P-Methylthioamphetamine or 4-Methylthioamphetamine, as referred to in Council Decision 1999/615/JHA [1].
Stajalište Europskog parlamenta od 24. listopada 2017.
Paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane, as referred to in Council Decision 2002/188/JHA [2].
(još nije objavljeno u Službenom listu).
2,5-dimethoxy-4-iodophenethylamine, 2,5-dimethoxy-4-ethylthiophenethylamine, 2,5-dimethoxy-4-(n)-propylthiophenethylamine and 2,4,5-trimethoxyamphetamine, as referred to in Council Decision 2003/847/JHA [3].
[3] Okvirna odluka Vijeća 2004/757/PUP od 25. listopada 2004. o utvrđivanju minimalnih odredaba vezanih za elemente kaznenih djela i sankcija u području nezakonite trgovine drogom (SL L 335, 11.11.2004., str. 8.).
enzylpiperazine or 1-benzyl-1,4-diazacyclohexane or N-benzylpiperazine or benzylpiperazine, as referred to in Council Decision 2008/206/JHA [4].
Zajednička akcija 97/396/PUP od 16. lipnja 1997. koju je donijelo Vijeće na temelju članka K.3 Ugovora o Europskoj uniji vezano uz razmjenu informacija, procjenu rizika i kontrolu novih sintetičkih droga (SL L 167, 25.6.1997., str. 1.).
ethylmethcathinone, as referred to in Council Decision 2010/759/EU [5].
Odluka Vijeća 2005/387/PUP od 10. svibnja 2005. o razmjeni informacija, procjeni rizika i kontroli novih psihoaktivnih tvari (SL L 127, 20.5.2005., str. 32.).
ethyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45), as referred to in Council Implementing Decision (EU) 2015/1873 [6].
Uredba (EU) 2017/2101 Europskog parlamenta i Vijeća od 15. studenoga 2017. o izmjeni Uredbe (EZ) br. 1920/2006 u pogledu razmjene informacija, sustava ranog upozoravanja i postupka procjene rizika novih psihoaktivnih tvari (vidjeti str.
ethylamphetamine, as referred to in Council Implementing Decision (EU) 2015/1874 [7].
1 ovog Službenog lista).
odo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), as referred to in Council Implementing Decision (EU) 2015/1875 [8].
SL L 123, 12.5.2016., str. 1.